NCT02232191View on ClinicalTrials.gov

Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Asplenia

Interventions

BIOLOGICAL

Pneumovax-23

Trial Locations (1)

95817

RECRUITING

University of California, Davis Medical Center, Sacramento

All Listed Sponsors

lead

University of California, Davis

OTHER